Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

New nomogram better predicts bladder cancer risk

Key clinical point: A new and simple nomogram for predicting the risk of bladder cancer in patients with microscopic hematuria could optimize the diagnostic evaluation process.

Major finding: The area under the curve (AUC) in the training and validation set was 0.79 and 0.74, respectively.

Study details: A retrospective analysis of 4,178 patients with microscopic hematuria.

Disclosures: The study was funded by the National Institutes of Health and the American Association of Medical Colleges. The authors reported having no conflicts of interest.


Matulewicz RS et al. Urol Oncol. 2020 Jan 14. doi: 10.1016/j.urolonc.2019.12.010.